These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1968518)

  • 21. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Close clinical observation minimizes the complications of beta-blocker withdrawal.
    Eisele G; Gilmore LL; Blanchard EB
    Ann Pharmacother; 1994; 28(7-8):849-51. PubMed ID: 7949498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure.
    Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tazaki J; Natsuaki M; Kimura T;
    Int J Cardiol; 2013 Sep; 168(2):774-9. PubMed ID: 23127614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of coronary heart disease: stable angina, acute coronary syndrome, myocardial infarction.
    Mehta SB; Wu WC
    Prim Care; 2005 Dec; 32(4):1057-81. PubMed ID: 16326227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The coronary hypertensive: therapeutic principles].
    Gosse P; Aouizerate E; Roudaut R; Dallocchio M
    Ann Cardiol Angeiol (Paris); 1986; 35(7):397-401. PubMed ID: 2879503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Sever PS; Chang CL; Prescott MF; Gupta A; Poulter NR; Whitehouse A; Scanlon M
    Eur Heart J; 2012 Dec; 33(23):2970-9. PubMed ID: 22942337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diuretic therapy for hypertension and the risk of primary cardiac arrest.
    Siscovick DS; Raghunathan TE; Psaty BM; Koepsell TD; Wicklund KG; Lin X; Cobb L; Rautaharju PM; Copass MK; Wagner EH
    N Engl J Med; 1994 Jun; 330(26):1852-7. PubMed ID: 8196728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors of recurrent angina after acute coronary syndrome: the global registry acute coronary events from China (Sino-GRACE).
    Zhao FH; Chen YD; Song XT; Pan WQ; Jin ZN; Yuan F; Li YB; Ren F; Lü SZ;
    Chin Med J (Engl); 2008 Jan; 121(1):12-6. PubMed ID: 18208658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolving role of β-adrenergic receptor blockers in managing hypertension.
    Poirier L; Lacourcière Y
    Can J Cardiol; 2012 May; 28(3):334-40. PubMed ID: 22595449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Beta receptor blockers in the therapy of coronary disease].
    Rettig G
    ZFA (Stuttgart); 1980 Mar; 56(9):600-5. PubMed ID: 6103604
    [No Abstract]   [Full Text] [Related]  

  • 31. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.
    Dunder K; Lind L; Lagerqvist B; Zethelius B; Vessby B; Lithell H
    Am Heart J; 2004 Mar; 147(3):502-8. PubMed ID: 14999201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes.
    Willett WC; Green A; Stampfer MJ; Speizer FE; Colditz GA; Rosner B; Monson RR; Stason W; Hennekens CH
    N Engl J Med; 1987 Nov; 317(21):1303-9. PubMed ID: 3683458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic factors in myocardial infarction--Results from a candidate gene and a genome-wide approach between beta blockers].
    Hengstenberg C; Bröckel U; Holmer S; Mayer B; Fischer M; Baessler A; Erdmann J; Lieb W; Löwel H; Riegger G; Schunkert H
    Herz; 2002 Nov; 27(7):649-61. PubMed ID: 12439636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease.
    Andersson C; Shilane D; Go AS; Chang TI; Kazi D; Solomon MD; Boothroyd DB; Hlatky MA
    J Am Coll Cardiol; 2014 Jul; 64(3):247-52. PubMed ID: 25034059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Do beta-blockers prevent coronary events in hypertensive patients?].
    Diévart F; Ragot S; Julien J; Herpin D
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):881-8. PubMed ID: 16231574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of myocardial infarction with combination antihypertensive regimens including a dihydropyridine calcium channel blocker in hypertensive diabetics.
    Anderson RJ; Alabi RA; Kelly WN; Diseker R; Roblin D
    J Manag Care Pharm; 2003; 9(1):29-35. PubMed ID: 14613359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
    Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
    Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.